Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Lamivudine solid dispersion, and preparation method, pharmaceutical composition and use of the dispersion

A solid dispersion, lamivudine technology, applied in the field of medicine, can solve the problems of high production cost, many influencing factors, operator injury and so on

Inactive Publication Date: 2013-11-20
ANHUI PIOM PHARMA
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the preparation process of microspheres is cumbersome, and there are many influencing factors. Microspheres with high drug loading (drug loading is often less than 30%) cannot be obtained. The production cost is relatively large, and the participation of organic solvents is often required, which is harmful to operators. Great damage, also has a certain damage to the environment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lamivudine solid dispersion, and preparation method, pharmaceutical composition and use of the dispersion
  • Lamivudine solid dispersion, and preparation method, pharmaceutical composition and use of the dispersion
  • Lamivudine solid dispersion, and preparation method, pharmaceutical composition and use of the dispersion

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Feeding amount:

[0060] Lamivudine 6.0g

[0061] mPEG-PLA (Mw=750 / 10000) 6.0g

[0062] Triethyl citrate 1.8g

[0063] Cholesterol 0.12g

[0064] Povidone K30 0.08g

[0065] Preparation method: Take mPEG-PLA, lamivudine, triethyl citrate, cholesterol, povidone K30, mix well, heat to melt, shear until evenly mixed, cool, pulverize, collect solid dispersion, namely have to.

[0066] Lamivudine content: 39.7%.

[0067] In this example, the molecular structural formula of mPEG-PLA is

[0068]

[0069] Among them: m≈17, n≈138.

Embodiment 2

[0071] Feeding amount:

[0072] Lamivudine 8.4g

[0073] mPEG-PLA (Mw=2000 / 5000) 5.6g

[0074] Preparation method: Take mPEG-PLA and lamivudine, mix them evenly, heat until melted, shear until mixed evenly, cool, pulverize, and collect the solid dispersion to obtain the product.

[0075] Lamivudine content: 60.2%.

[0076] In this example, the molecular structural formula of mPEG-PLA is

[0077]

[0078] Among them: m≈45, n≈69.

Embodiment 3

[0080] Feeding amount:

[0081] Lamivudine 0.8g

[0082] mPEG-PLA (Mw=2000 / 80000) 8.0g

[0083] Preparation method: Take mPEG-PLA and lamivudine, mix them evenly, heat until melted, shear until mixed evenly, cool, pulverize, and collect the solid dispersion to obtain the product.

[0084] Lamivudine content: 8.5%.

[0085] In this example, the molecular structural formula of mPEG-PLA is

[0086]

[0087] Among them: m≈45, n≈1111.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to lamivudine solid dispersion and a preparation method and a use of the lamivudine solid dispersion. The lamivudine solid dispersion provided by the invention is prepared by using a methoxy-terminated polyethylene glycol-polylactic acid block copolymer and derivatives of the block copolymer, polylactic acid, polylactic acid-glycolic acid copolymer or polycaprolactone as carrier materials by a hot melting method. The preparation method of the lamivudine solid dispersion provided by the invention avoids use of an organic solvent. The lamivudine solid dispersion provided by the invention can be applied in subcutaneous injection or intramuscular injection for treating chronic hepatitis B.

Description

technical field [0001] The invention relates to the technical field of medicine. Specifically, the present invention relates to a lamivudine solid dispersion, as well as the preparation method and application of the solid dispersion. Background technique [0002] Lamivudine, English name Lamivudine, chemical name: (2R-cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimidine -2-ketone is mainly used clinically to treat chronic hepatitis B. [0003] Lamivudine is a nucleoside analog, and nucleotides are the raw materials for the synthesis of human genetic material DNA and RNA (DNA and RNA are actually composed of many nucleotides arranged in a long string hand in hand). Nucleoside analogs mimic the structure of nucleotides in structure, but do not have the function of nucleotides. Therefore, in the process of DNA synthesis, nucleoside analogs can be incorporated, but they cannot synthesize nucleic acid chains with normal functions, so that the replication of the v...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/00A61K31/513A61K47/34A61P1/16A61P31/20
Inventor 胡忍乐王九成焦亚奇丁多浩孙亚利夏磊吴建立
Owner ANHUI PIOM PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com